Based on the hypothesis that catecholamine decreases may cause increases in biopterin, we measured the GTP cyclohydrolase I(GTPCH-I) activity and biopterin content in the cerebral cortex, midbrain/diencephalon, cerebeilum, pons/medulla oblongata, striatum , and hippocampus of brains from rats given NSDlOIS, an inhibitor for aromatic amino acid decarboxylase . The catecholamine contents decreased in all the regions tested. The changes in the GTPCH -I activity and bioptcrin content were different among the regions; they decreased in some regions contrary to expectations and increased in other regions. However, either the enzyme activity or biopterin content increased in the midbrain/ diencephalon and pons/ medulla oblongata, in which similar levels of catecholamines, GTPCH -I activity and biopterin were detected. These results suggest that for the midbrain/diencephalon and pons/medulla oblongata the surmise that a decrease in catecholamines causes an increase in the biopterin synthesis may be correct.
Introduction
GTP cydohydrolase I (EC 3.4.S .16) (GTPCH-I) is the enzyme that catalyzes the formation of Derythro-dihydroneopterin triphosphate from GTP (1) . This is the first step in tetrahydrobiopterin biosynthesis . The biopterin is a cofactor of aromatic amino acid hydroxylase, which catalyzes the biosynthesis of catecholamines and S-hydroxy-tryptamine (2, 3) , and presumably is an essential factor for the production of nitric oxide(NO) from arginine ( 4) . Nitric oxide has been widely studied in immune system and apoptosis as well as neurochemistry. Since GTPCH-I is the rate limiting enzyme in many mammals, although not in man (5) , and since the concentration of tetrahydrobioptcrin affects catecholamine ~ynthesis (6, 7, 8) , we intended to know whether decreases in catecholamine may cause increases in biopterin, and conversely whether catecholamine increases may C2.use biopterin decreases. 3-hydroxybenzylhydrazine(NSD-l 0 15), an enzyme inhibitor for aromatic L-amino acid decarboxylase (EC 4.1.1.28) (AADC) was given to rats to decrease the catecholamine levels (9) , and the GTPCH-I activity, together with the neopterin and biopterin contents in the brain were measured. The cltcch olamine contents were also determined in the ,·an-ous regions of the rat brains. . Guanosine 5 r -triphosphate disodium salt was purchased from Wako Pure Chemical (Osaka, Japan). Deverosil-ODS, K-S (4.6 x 250 mm) column was purchased from Nomura chemical (Aichi, Japan). All other reagents were analytical grade. For each experiment the NSD-IOI5 ( 100 mg/ kg) was injected intraperitoneally to 7 Wistar rats at 7 weeks of age, and the rats decapitated after 2 hr ( 10) . Seven rats for the control group were injected with phosphate-buffered saline. The brain was rapidly dissected out and separated into the regions of cerebral cortex, midbrain/diencephalon, cerebellum, pons/ medulla, striatum, and hippocampus on a chilled pad that had been frozen in a ~Wo C-deep freezer (II) . The separated brain regions were stored at -sonc until analysis.
Materials and Methods

NSD
Triplicate determinations were carried out in all experiments, and the highest and lowest values obtained from the 7 rats in a single experiment for each drug were discarded, i.e. the mean value was calculated from 5 out of 7 values obtained.
The tissue was homogenized in 4 volumes of homogenizing buffer A (50 mM potassium phosphate buffet, pH 7 .0 containing ] mM EDTA and 0.2 mM phenylmethylsulfonyl fluoride) with 20 sec puises using a Polytron homogenizer (Kinematika, GmbH, Switzerland) four times . The supernatant solution obtained after centrifugation at 12,000 X g tor 30 min was used for the enzyme assays.
The enzyme activity was assayed according to the methods descrihed by Sawada et al. (12) and Hatakeyama et al. (13) The reaction mixture ( 100 ~l ) containillg 1 0 ~l f)f 10 mM GTP, I 0 ~l of 25 mM EDTA, 10 ~l of 1 M Tris, pH 7.S with 0.5 M KCI, 20 ~l of 50% glycerol and 50 ~l of enzyme preparation was incubated at 37"C for 60 min in the dark. The mixture was then oxidized by the addition of I 0 ~l of a solution containing I % iodine and 2% KI in IN Hel and a further incubation in the dark for 60 min. The oxidation was terminated by the addition of 10 ~l of 2% ascorbic acid. The neopterin triphosphate formed was de phosphorylated by the addition of 13 ~l of 2M NaOH followed by 9 units (15 ~l) of alkaline phosphatase and a subsequent incubation for 60 min at 37"C in the dark. The reaction was terminated by the add~tion of 13 ~l of 2 M acetic acid solution. After centrifugation, the supernatant solution was injected on a HPLC column (Deverosil-ODS, K-S). HPLC was performed using a JASCO Trirotor (Nihon Bunko, Tokyo, Japan) attached to a spectrofluorometer (FP-2IO Spectrofluorometer, Nihon Bunko, Tokyo, Japan). The fluorescence was measured at 450 nm with the excitation at 350 nm. The mobile phase buffer for the HPLC was 10 mM sodium phosphate buffer, pH 7.0, containing 1 mM EDTA with a flow rate of LO mljmin.
Endogenous neopterin and biopterin in the tissue were determined by the method for GTPCH-I with a little modification, i.e . the supernatant of the homogenate which resulted from centrifugation at 12,000 x g for 20 min was directly analyzed by HPLC without incubation for GTPCH -I and oxidation.
The tissue was homogenized in 9 volumes of homogenizing buffer B ( 50 mM Tris buffer, pH 7.2 containing 5 mM EDTA and protease inhibitors such as 2 .0 mg leupeptin, 5.0 mg trypsin inhibitor and 15 .0 mg benzamidine/l) using a small glass homogenizer. The homogenate of striatum only was then diluted to one-twentieth with the homogenizing buffer B. Ten micro liters of each homogenate, including the diluted-homogenate of striatum, were further diluted with 190 ~l of the homogenizing buffer B. Ten micro liters of each diluted homogenate was then further diluted with 590 f..ll of water. The sample was mixed immediately after the addition of water, and the diluted preparation deproteinized by the addition of 300 f..ll of 5% perchloric acid. Following the addition of 1 00 ~ of 1.5 M sodium acetate the deproteinized preparation was centrifuged at 12,000 x g for 10 min. The supernatant obtained was analyzed by HPLC-fluorometry (excitation at 340 nm and emission at 470 nm) based on proclaim derivatization of catecholamine with diphenylethylendiamine using a TOSOH full automated catecholamine analyzer (HLC-725CA, TOSOH, Tokyo, Japan).
Result
The catecholamine contents in various regions of the rat brain and the influences of NSD-I015 treatment are shown in Table 1 . The major catecholamine in the cerebral cortex, midbrain/diencephalon, pons/ medulla oblongata, cerebellum, and hippocampus was NE. Its contents in the cerebral cortex, midbrain/diencephalon and pons/ medulla oblongata were between 2.55-2.S6, and Pteridines/ Vol. 8/ No. 3 those in the cerebellum and hippocampus were between 1.51-1.85 nm.ol/ g wet tissue. In these regions the DA content as compared with the NE content were as follows; about half in the cerebral co rtex , about 1/ 8 and 1/ 10 in the midbrain / diencephalon and pons/ medulla oblongata, rcspectiyely, and about 1/30 in the hippocampus. The ;-...'E content in the cerebellum was lower than the sensitivity limit of this method. The major catecholamine in the striatum was DA, at 45 .0 nmol/g wet tissue while the NE content was low at about 1/ 83 of the DA content. The NSD-I0lS treatment decreased the DA and NE content in the aU regions determined in this study, however, the degrees of decrease varied among the different re gions of the brain . The region most affected was thc hippocampus, in which NE content decreased to as low as 27% of the control. The influence of the treatment was comparably small in the midbrain / diencephalon and pons/medulla oblongata regions, where the NE content decreased to about 86% and 87%, of the control respectively (Table 1) .
GTPCH -I activity and biopterin content in the various regions of the rat brain, and the influences of NSD-I0lS treatment on the activity and content are show in Table 1 . The GTPCH-I activity per unit wet weight of tissue was highest in the striatum. This was followed by the midbrain/diencephalon and pons/medulla oblongata, in which the activity was about 1/ 2.5 of that in the striatum, and then the cerebral cortex and hippocampus, in which the activity was about 1/ 5.4 of that in the striatum. The GTPCH-I activity in the cerebellum was the lowest at about 1/ l4 .5 of that in the striatum .
The biopterin content in the various regions of the rat brairl was not parallel to the GTPCH-I activity of each region . The concentration was highest in the striatum, and next highest in the cerebral cortex, where the concentration was about 1/ 2.7 of that of the striatum. The concentrations in the midbrain/ diencephalon, cerebellum, pons/ medulla oblongata, and hippocampus were about the same levels at 1/ 6.3-1/5.0 of that in the striatum, respectively .
The ratio of biopterin content (pmoljg wet tissue) to GTPCH-I activity (pmoljmin/ g wet tissue ) was calculated to investigate a possible relatlonship. The regions in decreasing order of the ratios were the midbrain/diencephalon and pons/ medulla oblongata (ratio about 4.2 and 6, respectively), striatum and hippocampus (about 11), cerebral cortex (about 21), and cerebellum (about 31). No mutual relationship was not estimated from the above results .
The influences of the NSD-I015 treatment on the GTPCH-I activity were different in the various regions. The enzyme activity was increased in the midbrain/ diencephalon and pons/medulla oblongata; and decreased in the cerebral cortex, striatum, and hippocampus. The enzyme activity in the cerebellum was hardly changed. No dear relationship was detected between the changes in enzyme activity and catecholamine contents by the NSD-101S treatment in the various regions.
The influence n~--::~1~ ~" II -1 0 1;:; treatment on the biopterin con:.::-: : > __ _:~~-c;c~t in the ' -arious regions . Th.: b l()ptcnn concentration 111-creased in the midbrain/ diencephalon, cerebellum, pons/ medulla oblongata, and striatum; and unchanged in the cerebral cortex and hippocampus. There was no definite relationship between the changes in the biopterin concentration and GTPCH-I activity, or between changes in the biopterin concentra.tion a.nd the ca.techola.mme contents in any of the various regions.
Discussion
The relationship between the concentrations of catechotaITlines and biopterin was investigated. The striatum, which contained about a 12-to 30-fold higher concentration of catecholamines as compared to the other regions, and in which dopamine (45.5 nmoljg tissue ) was by far the predominant catecholamine, also contained about a 2.7-to 6.3-fold higher concentration of biopterin as compared to other regions. On the other hand, the midbrain/ diencephalon, cerebellum , pons/ medulla oblongata, and hippocaITlpus, which contained catecholamines in concentrations ranging from 1 .5-3 .2 nmoi!g tissue with about 2-fold differences in their concentration, contained biopterin in concentrations ranging froITl 118-148 nmotj g tissue showing about the same level. The cerebral cortex, midbrain/ diencephalon, and pons/ medulla oblongata, all contained about the same concentration of catecholamines at 3.2-3 .7 nmol/ g tissue , however the biopterin concentration of the cerebral cortex \vas about 2-fold higher than those of the midbrain/ diencephalon and pons/ medulla oblongata. These results indicate that there was no mutual relationship between the concentrations of catecholamines and biopterin, as had been reported by others (14 ) . While the NE concentrations of the cerebral cortex, midbrain / diencephalon and pons/ medulla oblongata were about the same level at 2.6-2 .9 nmol/ g tissue , the DA concentration was about 3 .0-to 3.7-fold higher in the cerebral cortex than in the midbrain/ diencephalon and pons/ ITledulla oblongata. Some sort of relation might be latent between the concentrations of DA and biopterin, although no speculation will be discussed.
The decreases in catecholamine concentration, and changes in GTPCH-I activity and biopterin concentration differed amo ng the regions. There also no clear relationships between the changes in GTPCH-I activity and the biopterin concentration . These facts may indicate that the regulatory mechanisms of catecholamines and biopterin and their susceptibility to drugs differ among the regions (I5) .
No definite relationships between the decrease in catecholamine concentration and changes in GTPCH-I activity, or between the catecholaITline decrease and changes in biopterin by the NSD-1015 treatment were recognized . However, as viewed from the rcidbra.inj diencepha.lon a.nd pons/ ITledulla oblongata, an analysis of the two regions showed that their behavior was considerably similar. The major catecholamine in both was NE , of which the concentration was about the same, and the GTPCH-I acuvlty, biopterin concennation, extent of decrease in NE content by neatment with NSD-1015 and extent of increase in GTPCH -I activity and biopterin concentration were relatively similar in the two regions.
The decrease in catecholamine may produce the increases in GTPCH -I activity and biopterin concentration in the midbrain/ diencephalon and pons/ medulla oblongata. Since the ratios of biopterin concentration to GTPCH -I activity in the midbrain/ diem:ephalon and pons/ medulla oblongata were 4.2 and 6.0, respectively, smaller than compared with those of the other regio ns, it might suggest that GTPCH-I plays a predominant role as the late limiting enzyme in the biosynthesis of biopterin ( 1 ) . If this hypothesis is correct, then the relationships between the catecholamine concentration and biopterin metabolism which are estimated in the midbrain/ diencephalon and pons/medulla oblongata as discussed above can not be considered to apply to the other regions, even if some unelucidated relationships ( 16) lay as yet among the analyzes 111 this study.
